AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

NASDAQ:ABCL

Overview | Financials
Company Name AbCellera Biologics Inc.
Symbol ABCL
Currency USD
Price 2.77
Market Cap 818,163,820
Dividend Yield 0%
52-week-range 2.335 - 5.62
Industry Biotechnology
Sector Healthcare
CEO Dr. Carl L.G. Hansen Ph.D.
Website https://www.abcellera.com

An error occurred while fetching data.

About AbCellera Biologics Inc.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or

Related Stocks

Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc.

FATE

1.255 USD

Canopy Growth Corporation logo

Canopy Growth Corporation

CGC

2.22 USD

Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc.

FOLD

9.21 USD

Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated

CORT

51.66 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

17.22 USD

Allscripts Healthcare Solutions, Inc. logo

Allscripts Healthcare Solutions, Inc.

MDRX

9.25 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

1.18 USD

Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc.

ALHC

13.51 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

41.81 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

23.3 USD

Financials

Numbers are in millions USD

Numbers are in millions USD